CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis

Open access
Luo, Jie, Shen, Li, Zheng, Di · 2014 · Scientific Reports

Abstract

Epidermal growth factor receptor (EGFR) mutation is a reliable and sensitive biomarker for EGFR-TKI therapy in non-small-cell lung cancer (NSCLC). However, detection of EGFR mutation in tissues has obvious limitations. Circulating free DNA (cfDNA) has been reported as an alternative approach for the detection of EGFR mutations. This systematic review and meta-analysis was designed to assess the diagnostic performance of cfDNA, compared with tissues. True-positive (TP), false-positive (FP), false-negative (FN), and true-negative (TN) values were extracted or calculated for each study. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were calculated. A summary receiver operating characteristic curve (SROC) and area under curve (AUC) were used to evaluate the overall diagnostic performance. 20 eligible studies involving 2012 cases were included in this meta-analysis. The pooled sensitivity, specificity, PLR, NLR, and DOR were 0.674 (95%CI: 0.517-0.800), 0.935 (95%CI: 0.888-0.963), 10.307 (95%CI: 6.167-17.227), 0.348 (95%CI: 0.226-0.537), and 29.582 (95%CI: 4.582-60.012), respectively. The AUC was 0.93 (95% CI: 0.90-0.95). The meta-analysis suggests that detection of EGFR mutation by cfDNA is of adequate diagnostic accuracy and cfDNA analysis could be a promising screening test for NSCLC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep06269

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of study selection.
Figure 1 Flow diagram of study selection.CC BY-NC-ND · PubMed Central
Figure 2 Forest plots of sensitivity and specificity of cfDNA. The pooled sensitivity was 0.691 (95% CI: 0.569–0.790) and the pooled specificity was 0.922 (95% CI: 0.878–0.951).
Figure 2 Forest plots of sensitivity and specificity of cfDNA. The pooled sensitivity was 0.691 (95% CI: 0.569–0.790) and the pooled specificity was 0.922 (95% CI: 0.878–0.951).CC BY-NC-ND · PubMed Central
Figure 3 The summary operative receiver characteristic curve indicated high diagnostic accuracy (A, the area under summary receiver characteristics curve was) and Fagan plot presents the clinical utility of cfDNA (B).
Figure 3 The summary operative receiver characteristic curve indicated high diagnostic accuracy (A, the area under summary receiver characteristics curve was) and Fagan plot presents the clinical utility of cfDNA (B).CC BY-NC-ND · PubMed Central
Figure 4 Deek's funnel plot showed no significant publication bias (A) and sensitivity analysis showed that the pooled results were robust and not affected by individual studies (B). The P value of Deek's funnel plot was 0.243, indicating no significant publication bias.
Figure 4 Deek's funnel plot showed no significant publication bias (A) and sensitivity analysis showed that the pooled results were robust and not affected by individual studies (B). The P value of Deek's funnel plot was 0.243, indicating no significant publication bias.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 212

Metadata

Authors
Luo, J., Shen, L., & Zheng, D.
Affiliations
Tongji University (CN)
Corresponding author
Zheng, Di
Venue
Scientific Reports
Published
2014-09-09
Volume
4
Issue
1
Pages
6269-6269
ISSN
2045-2322 (ISSN-L)
OpenAlex
W1979671400
Cited by
212
References
55
Citations by year
2026: 3 · 2025: 7 · 2024: 6 · 2023: 15 · 2022: 10 · 2021: 16 · 2020: 16 · 2019: 21 · 2018: 33 · 2017: 40 · 2016: 25 · 2015: 20
FWCI
4.85
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
cell-free DNA, EGFR mutation, non-small cell lung cancer, liquid biopsy, diagnostic accuracy, EGFR tyrosine kinase inhibitors, tumor markers
MeSH terms
Erlotinib Hydrochloride, Gefitinib, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, DNA, Female, Humans, Lung Neoplasms, Male, Mutation, Quinazolines, ROC Curve, Biomarkers, Tumor, Area Under Curve, Protein Kinase Inhibitors, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.